Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 4 of 23

Cannabis Science (CBIS) Expands into Spanish Market; Specific Focus on Medical Research and Studies

Created on 2018-06-14 17:43:31

Cannabis Science (CBIS) Acknowledges Dr. Sanjay Gupta, CNN Chief Medical Correspondent, for Objectively Addressing Treatment Benefits of Cannabis for Several Critical Ailments in Tonight's CNN Special: 'Weed 2'

Created on 2018-06-14 16:42:17

Cannabis Science (CBIS) Announces Investors In Private Placement Include Weedmaps and Dutch Investment Company; Weedmaps and CBIS to Develop Joint Ventures and Marketing Relationship

Created on 2018-06-14 16:41:21

Cannabis Science (CBIS) Applauds Unprecedented United States Federal Government Approval of University Study of Medical Cannabis for Veterans Suffering from PTSD

Created on 2018-06-14 16:40:32

Cannabis Science Applauds Extending Legalization of Nevada Medical Cannabis Program and Continued Growth of the U.S. Industry; Examines Opportunities Presented by the Opening of the Nevada Market

Created on 2018-06-14 16:39:30

Cannabis Science, Inc. (CBIS) Commends Dr. Sanjay Gupta on His On-Going Contribution to Learning and Educating Regarding the Efficacy of Medical Cannabis for Patients In Need

Created on 2018-06-14 16:38:43

Cannabis Science Inc. Signs Agreement With MEDIWIET to Conduct Clinical Observational Study in the Netherlands

Created on 2018-06-14 16:37:39

Cannabis Science Supports Patients Out of Time's Eighth National Clinical Conference on Cannabis Therapeutics held May 8-10, 2014 in Portland, Oregon

Created on 2018-06-14 16:36:25

Cannabis Science Issues CBN Patent and R&D Progress Guidance for the 2nd Quarter of 2014

Created on 2018-06-14 16:35:03

Cannabis Science Inc. Moves Forward with MEDIWIET Preparing Observational Study in the Netherlands

Created on 2018-06-14 16:34:09

Cannabis Science Cheers Dr. Oz on Becoming a Vocal Supporter of Medical Marijuana on The Larry King Live Show

Created on 2018-06-14 16:33:07

Cannabis Science Operational Update: First Data from Preclinical Development Expected This Week; Cannabis Science Plans to Open Informational Hotline for General Public

Created on 2018-06-14 16:31:53

CBIS Reports on CBS News; Historic Marijuana Vote from United States House of Representatives Creates Serious Confidence as Marijuana Wins U.S. House Vote for First Time in History

Created on 2018-06-14 16:30:11

Cannabis Science, Inc. (CBIS) Reports Strongest Financial Position in its History, Citing Filings & Financial Statements as the Company Moves Forward with Multiple Cannabis Drug Development Programs

Created on 2018-06-14 16:28:45

Cannabis Science, Inc. (CBIS) Prepares for New York State as it Becomes the 23rd State to Authorize Medical Marijuana Use

Created on 2018-06-14 16:27:57

CFO Journal, Part of the Wall Street Journal, Addresses Business Challenges of Cannabis Industry in the Article "Pot Industry Puts on a Tie"Referencing Cannabis Science, Inc. (CBIS) Chief Financial Officer, Robert Kane

Created on 2018-06-14 16:26:59

Cannabis Science Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (retired) for a Second Term on the Scientific Advisory Board as Special Senior Advisor to the Company

Created on 2018-06-14 16:25:54

Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change

Created on 2018-06-14 16:25:00

CBIS Very Excited Over Federal Cannabis Legalization Efforts in U.S. House and Senate to Change Medical Cannabis Laws

Created on 2018-06-14 16:23:41

Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders

Created on 2018-06-14 16:21:46

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.